Form 4: ImmuCell Director David Tomsche Acquires Additional Shares
SEC Form 4 Filing
Director David Tomsche acquired 2,186 shares of ImmuCell Corp common stock at $3.55 per share on August 28, 2024.
Summary
- On August 28, 2024, David Tomsche, a director of ImmuCell Corp, purchased 2,186 shares of the company's common stock.
- The purchase price was $3.55 per share.
- Following the transaction, Tomsche directly owns 131,797 shares, which includes 6,987 shares held by immediate family members.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but the scale of the purchase is not significant enough to indicate strong conviction.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Insider transactions are closely monitored as they can provide insights into a company's performance and future expectations within the animal health industry.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 08/28/2024 | Date of transaction: David Tomsche acquired 2,186 shares of ImmuCell Corp common stock. |
| 08/30/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.